Author

Paolo Gallipoli

ORCID 0000-0001-7254-2253Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Alex von KriegsheimiD· 1 shared Ana Rio-MachiniD· 1 shared Andrew J. FinchiD· 1 shared Aoife M. S. Magee· 1 shared Barrie PeckiD· 1 shared Bela PateliD· 1 shared Céline PhilippeiD· 1 shared Diego Pereira-Martins· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alex von KriegsheimORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivAug 2, 2023

SCD inhibition eradicates AML displaying high de novo fatty acid desaturation and synergizes with chemotherapy

Vilma Dembitz, Hannah Lawson, Richard Burt…·Paolo Gallipoli

SCD inhibition induces AML cell death and synergizes with chemotherapy to prolong survival in murine AML models.

DOI 10.1038/s41375-024-02390-9

mousebulk RNA-seq

𝕏 PostBluesky